Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1Gynecologic 1

Conditions

Breast Neoplasms 8Polycystic Ovary Syndrome 3Peripheral Nervous System Diseases 2Obesity 2Neoplasms 2Head and Neck Neoplasms 2Endometrial Neoplasms 2Triple Negative Breast Neoplasms 1Tracheal Diseases 1TP53 Y220C Mutation 1Squamous Cell Carcinoma of Head and Neck 1Smoking 1Small Cell Lung Carcinoma 1Sarcoma, Synovial 1Sarcoma, Alveolar Soft Part 1Sarcoma 1Salivary Gland Neoplasms 1Rectal Neoplasms 1Pulmonary Disease, Chronic Obstructive 1Pancreatic Neoplasms 1Overweight 1Osteosarcoma 1Neuroblastoma 1Neoplasm Metastasis 1Nasopharyngeal Neoplasms 1Multiple Myeloma 1Motor Activity 1Mesothelioma 1Meningioma 1Medulloblastoma 1

Interventions

Letrozole 3Uterine Myomectomy 2Tamoxifen 2Metformin 2Inositol 2Tablets 1Psychiatric Rehabilitation 1Megestrol Acetate 1Lactalbumin 1Congresses as Topic 1Clomiphene 1Arthroplasty, Replacement, Hip 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Infertility × Tablets × 1 year × Clear all
NCT05316467 2026-06-04

Weight Management Plus Megestrol Acetate in Early-stage Endometrioid Carcinoma

Fudan University

Phase 2/3 Terminated
8 enrolled
GynecologicOther

Infertility, Obesity, Endometrial Neoplasms, Overweight

Data powered by HemOnc (CC BY 4.0) Colophon âš¡